Eosinophilic Esophagitis

Overview

Journal Allergy Asthma Clin Immunol

Specialty Allergy & Immunology

Date 2024 Dec 20

PMID 39702284

Authors

Stephanie C Erdle

Stuart Carr

Edmond S Chan

Kara Robertson

Wade Watson

Affiliations

Soon will be listed here.

Abstract

Eosinophilic esophagitis (EoE) is an atopic condition of the esophagus that has become increasingly recognized. Diagnosis of the disorder is dependent on the patient's clinical manifestations and must be confirmed by histologic findings on esophageal mucosal biopsies. The epidemiology, pathophysiology, diagnosis, treatment, and prognosis of EoE are discussed in this review.

Citing Articles

Food oral immunotherapy.

McHenry M, Begin P, Chan E, Latrous M, Kim H Allergy Asthma Clin Immunol. 2025; 20(Suppl 3):82.

PMID: 39940042 PMC: 11823072. DOI: 10.1186/s13223-025-00948-5.

Asthma.

OKeefe A, Connors L, Ling L, Kim H Allergy Asthma Clin Immunol. 2025; 20(Suppl 3):81.

PMID: 39930536 PMC: 11808942. DOI: 10.1186/s13223-025-00949-4.

References

Konikoff M, Noel R, Blanchard C, Kirby C, Jameson S, Buckmeier B . A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis. Gastroenterology. 2006; 131(5):1381-91. DOI: 10.1053/j.gastro.2006.08.033. View

Chang N, Thakkar K, Ketchem C, Eluri S, Reed C, Dellon E . A Gap in Care Leads to Progression of Fibrosis in Eosinophilic Esophagitis Patients. Clin Gastroenterol Hepatol. 2021; 20(8):1701-1708.e2. PMC: 9043028. DOI: 10.1016/j.cgh.2021.10.028. View

Wen T, Dellon E, Moawad F, Furuta G, Aceves S, Rothenberg M . Transcriptome analysis of proton pump inhibitor-responsive esophageal eosinophilia reveals proton pump inhibitor-reversible allergic inflammation. J Allergy Clin Immunol. 2014; 135(1):187-97. PMC: 4289084. DOI: 10.1016/j.jaci.2014.08.043. View

Putnam P . Eosinophilic esophagitis in children: clinical manifestations. Gastrointest Endosc Clin N Am. 2007; 18(1):11-23. DOI: 10.1016/j.giec.2007.09.007. View

Miehlke S, Hruz P, Vieth M, Bussmann C, von Arnim U, Bajbouj M . A randomised, double-blind trial comparing budesonide formulations and dosages for short-term treatment of eosinophilic oesophagitis. Gut. 2015; 65(3):390-9. PMC: 4789829. DOI: 10.1136/gutjnl-2014-308815. View

Philpott H, Kweh B, Thien F . Eosinophilic esophagitis: current understanding and evolving concepts. Asia Pac Allergy. 2017; 7(1):3-9. PMC: 5287068. DOI: 10.5415/apallergy.2017.7.1.3. View

Molina-Infante J, Ferrando-Lamana L, Ripoll C, Hernandez-Alonso M, Mateos J, Fernandez-Bermejo M . Esophageal eosinophilic infiltration responds to proton pump inhibition in most adults. Clin Gastroenterol Hepatol. 2010; 9(2):110-7. DOI: 10.1016/j.cgh.2010.09.019. View

Wilson B, Meltzer E, Wright B . Ethical Implications of Continuing Oral Immunotherapy After the Development of Eosinophilic Esophagitis. J Allergy Clin Immunol Pract. 2023; 11(12):3638-3644. PMC: 10843091. DOI: 10.1016/j.jaip.2023.08.012. View

Goldberg M, Nachshon L, Levy M, Elizur A, Katz Y . Risk Factors and Treatment Outcomes for Oral Immunotherapy-Induced Gastrointestinal Symptoms and Eosinophilic Responses (OITIGER). J Allergy Clin Immunol Pract. 2019; 8(1):125-131. DOI: 10.1016/j.jaip.2019.07.034. View

10.

Straumann A, Conus S, Degen L, Frei C, Bussmann C, Beglinger C . Long-term budesonide maintenance treatment is partially effective for patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2011; 9(5):400-9.e1. DOI: 10.1016/j.cgh.2011.01.017. View

11.

Lucendo A, Miehlke S, Schlag C, Vieth M, von Arnim U, Molina-Infante J . Efficacy of Budesonide Orodispersible Tablets as Induction Therapy for Eosinophilic Esophagitis in a Randomized Placebo-Controlled Trial. Gastroenterology. 2019; 157(1):74-86.e15. DOI: 10.1053/j.gastro.2019.03.025. View

12.

Miehlke S . Clinical features of Eosinophilic esophagitis in children and adults. Best Pract Res Clin Gastroenterol. 2015; 29(5):739-748. DOI: 10.1016/j.bpg.2015.09.005. View

13.

Gonsalves N, Yang G, Doerfler B, Ritz S, Ditto A, Hirano I . Elimination diet effectively treats eosinophilic esophagitis in adults; food reintroduction identifies causative factors. Gastroenterology. 2012; 142(7):1451-9.e1. DOI: 10.1053/j.gastro.2012.03.001. View

14.

Kottyan L, Davis B, Sherrill J, Liu K, Rochman M, Kaufman K . Genome-wide association analysis of eosinophilic esophagitis provides insight into the tissue specificity of this allergic disease. Nat Genet. 2014; 46(8):895-900. PMC: 4121957. DOI: 10.1038/ng.3033. View

15.

Hirano I, Collins M, Assouline-Dayan Y, Evans L, Gupta S, Schoepfer A . RPC4046, a Monoclonal Antibody Against IL13, Reduces Histologic and Endoscopic Activity in Patients With Eosinophilic Esophagitis. Gastroenterology. 2018; 156(3):592-603.e10. DOI: 10.1053/j.gastro.2018.10.051. View

16.

Underwood B, Troutman T, Schwartz J . Breaking down the complex pathophysiology of eosinophilic esophagitis. Ann Allergy Asthma Immunol. 2022; 130(1):28-39. PMC: 10165615. DOI: 10.1016/j.anai.2022.10.026. View

17.

Spergel J . An allergist's perspective to the evaluation of Eosinophilic Esophagitis. Best Pract Res Clin Gastroenterol. 2015; 29(5):771-781. PMC: 4641822. DOI: 10.1016/j.bpg.2015.06.011. View

18.

Sleiman P, Wang M, Cianferoni A, Aceves S, Gonsalves N, Nadeau K . GWAS identifies four novel eosinophilic esophagitis loci. Nat Commun. 2014; 5:5593. PMC: 4238044. DOI: 10.1038/ncomms6593. View

19.

Spergel J, Rothenberg M, Collins M, Furuta G, Markowitz J, Fuchs 3rd G . Reslizumab in children and adolescents with eosinophilic esophagitis: results of a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol. 2011; 129(2):456-63, 463.e1-3. DOI: 10.1016/j.jaci.2011.11.044. View

20.

Gautam Y, Caldwell J, Kottyan L, Chehade M, Dellon E, Rothenberg M . Genome-wide admixture and association analysis identifies African ancestry-specific risk loci of eosinophilic esophagitis in African Americans. J Allergy Clin Immunol. 2022; 151(5):1337-1350. PMC: 10164699. DOI: 10.1016/j.jaci.2022.09.040. View